Stanford University study points to endocannabinoid deficiency as cause of Alzheimer’s

April 22, 2017

A new study led by investigators at the Stanford University School of Medicine has implicated the blocking of endocannabinoids — signaling substances that are the brain’s internal versions of the psychoactive chemicals in marijuana and hashish — in the early pathology of Alzheimer’s disease. Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis Health Radio © 2016